摘要:
Chroman derivatives of the formula I ##STR1## wherein R.sup.1 to R.sup.8 have the meanings defined herein, and their salts have an effect on the cardiovascular system.
摘要:
The invention relates to novel chroman derivatives of the formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8 and R.sup.9 have the meanings given in [Patent claim 1], and which, like their salts, show effects on the cardiovascular system and can be used for the treatment or prophylaxis of cardiac insufficiency, angina pectoris, high blood pressure, incontinence and alopecia.
摘要:
The invention relates to new chroman derivatives of the formula I ##STR1## in which R.sup.1 is A,R.sup.2 and R.sup.8 are each H or A,R.sup.1 and R.sup.2 together are also alkylene with 3-6 C atoms,R.sup.3 is OH, OA or OAc,R.sup.4 is H,R.sup.3 and R.sup.4 together are also a bond,R.sup.5 is Ar or C.sub.n H.sub.2n -R.sup.9,R.sup.9 is alkenyl or alkynyl with 2-4 C atoms in each case, OH, OA, CHO, CO-A, CS-A, COOH, COOA, COO-alkyl-Ar, CS-OA, NO.sub.2, NH.sub.2, NHA, NA.sub.2, CN, F, Cl, Br, I, CF.sub.3, SA, SO-A, SO.sub.2 -A or Ar,Ar is a phenyl group which is unsubstituted or substituted once or twice by R.sup.10, R.sup.6, R.sup.7 and R.sup.10 are each H, A, HO, AO, CHO, ACO, CF.sub.3 CO, ACS, HOOC, AOOC, AO-CS, ACOO, A-CS-O, hydroxy-alkyl, mercapto-alkyl, NO.sub.2, NH.sub.2, NHA, NA.sub.2, CN, F, Cl, Br, I, CF.sub.3, AS, ASO, ASO.sub.2, AO-SO, AO-SO.sub.2, AcNH, AO-CO-NH, H.sub.2 NSO, HANSO, A.sub.2 NSO, H.sub.2 NSO.sub.2, HANSO.sub.2, A.sub.2 NSO.sub.2, H.sub.2 NCO, HANCO, A.sub.2 NCO, H.sub.2 NCS, HANCS, A.sub.2 NCS, ASONH, ASO.sub.2 NH, AOSONH, AOSO.sub.2 NH, ACO-alkyl, nitro-alkyl, cyano-alkyl, A-C(.dbd.NOH), A-C(.dbd.NNH.sub.2), H.sub.2 PO.sub.3 or A.sub.2 PO.sub.3,n is 1, 2 or 3,A is alkyl with 1-6 C atoms,-alkyl is alkylene with 1-6 C atoms andAC is alkanoyl with 1-8 C atoms or aroyl with 7-11 C atoms,and the salts thereof which display effects on the cardiovascular system and can be used for the treatment or prophylaxis of heart failure, angina pectoris, high blood pressure, incontinence and alopecia.
摘要翻译:本发明涉及式Ⅰ的新的苯并二氢吡喃衍生物,其中R 1是A,R 2和R 8各自是H或A,R 1和R 2一起也是具有3-6个C原子的亚烷基,R 3是OH,OA或OAc R 4是H,R 3和R 4一起也是键,R 5是Ar或C n H 2n-R 9,R 9是每种情况下具有2-4个C原子的链烯基或炔基,OH,OA,CHO,CO-A,CS-A ,COOH,COOA,COO-烷基-Ar,CS-OA,NO2,NH2,NHA,NA2,CN,F,Cl,Br,I,CF3,SA,SO-A,SO2-A或Ar,Ar是 R 10,R 6,R 7和R 10未取代或取代一次或两次的苯基分别为H,A,HO,AO,CHO,ACO,CF 3 CO,ACS,HOOC,AOOC,AO-CS,ACOO,A-CS- O,羟基烷基,巯基烷基,NO2,NH2,NHA,NA2,CN,F,Cl,Br,I,CF3,AS,ASO,ASO2,AO-SO,AO-SO2,AcNH, NH,H2NSO,HANSO,A2NSO,H2NCO,HANCO2,A2NCO,H2NCS,HANCO,A2NCO,H2NCS,HANCS,A2NCS,ASONH,ASO2NH,AOSONH,AOSO2NH,ACO-烷基,硝基 - 烷基,氰基 - 烷基,AC(= NOH ),AC(= NNH 2),H 2 PO 3或A 2 PO 3,n为1,2或3,A为具有1-6个C原子的烷基, - 烷基为亚烷基 1-6个C原子,AC是具有1-8个C原子的烷酰基或7-11个C原子的芳酰基及其对心血管系统有影响的盐,可用于治疗或预防心力衰竭,心绞痛 ,高血压,失禁和脱发。
摘要:
4-amino-1-piperidylbenzoylguanidines of the formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3 and R.sup.4 have the given meanings, and also the physiologically compatible salts thereof, exhibit antiarrhythmic properties and act as inhibitors of the cellular Na.sup.+ /H.sup.+ antiporter.
摘要翻译:其中R 1,R 2,R 3和R 4具有给定含义的式I的4-氨基-1-哌啶基苯甲酰基胍以及其生理上相容的盐表现出抗心律失常性质,并且作为细胞Na + / H + 反倾销
摘要:
Ortho-substituted benzoic acid derivatives of the formula I ##STR1## in which R.sup.1, R.sup.2 and R.sup.3 have the given meanings, and Q is guanidyl, and also their physiologically harmless salts, exhibit antiarrhythmic properties and act as inhibitors of the cellular Na.sup.+ /H.sup.+ antiporter. In addition, the compounds of the formula I, in which R.sup.1 to R.sup.3 and also Q have the given meanings, are suitable for use as valuable intermediates for the preparation of medicaments, in particular of inhibitors of the cellular Na.sup.+ /H.sup.+ antiporter.
摘要翻译:其中R 1,R 2和R 3具有给定含义的式I的正构取代的苯甲酸衍生物,Q是胍基,以及它们的生理上无害的盐表现出抗心律失常性质,并且作为细胞Na + / H +反向运输商。 此外,其中R1至R3和Q具有给定含义的式I化合物适合用作制备药物,特别是细胞Na + / H +反转运体抑制剂的有价值的中间体。
摘要:
Heterocyclyloxybenzoylguanidines of the formula I ##STR1## in which R.sup.1, R.sup.2 and Het have the given meanings, and also the pharmaceutically acceptable salts thereof, exhibit antiarrhythmic properties and act as inhibitors of the cellular Na.sup.+ /H.sup.+ antiporter.
摘要翻译:其中R1,R2和Het具有给定含义的式I的杂环氧基苯甲酰基胍及其药学上可接受的盐显示出抗心律失常性质,并且作为细胞Na + / H +反转录酶的抑制剂。
摘要:
Arylbenzoylguanidines of the formula I ##STR1## in which R.sup.1 R.sup.2, R.sup.3 and Ph have the given meanings herein, and also the physiologically harmless salts thereof, exhibit antiarrhythmic properties and act as inhibitors of the cellular Na.sup.+ /H.sup.+ antiporter.
摘要翻译:其中R1 R2,R3和Ph具有给定含义的式I“I”的芳基苯甲酰基胍以及其生理上无害的盐表现出抗心律失常性质,并且作为细胞Na + / H +反向转运体的抑制剂。
摘要:
The present invention relates to an NHE-1 selective Na+/H+ antiporter inhibitor N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine, hydrochloride, to its hydrochloride hydrate, and to a process for the preparation.
摘要翻译:本发明涉及一种NHE-1选择性Na + / H +反转运蛋白抑制剂N-(4,5-二甲基乙磺酰基-2-甲基苯甲酰基)胍盐酸盐及其盐酸盐水合物及其制备方法。
摘要:
Benzoylguanidines of the formula I ##STR1## wherein R.sup.1 and R.sup.2 have the meanings indicated herein, and their physiologically acceptable salts, show anti-arrhythmic properties and act as inhibitors of the cellular NA.sup.+ /H.sup.+ antiporter.
摘要翻译:其中R 1和R 2具有本文所示含义的式I的苯甲酰基胍及其生理上可接受的盐显示抗心律失常性质,并且作为细胞NA + / H +反转录酶的抑制剂。
摘要:
4-Mercaptobenzoylguanidines of the formula I ##STR1## in which A, R.sub.1, R.sub.2 and R.sub.3 have the meanings given, and the physiologically unobjectionable salts thereof exhibit antiarrhythmic properties and are active as inhibitors of the cellular Na.sup.+ /H.sup.+ antiporter.
摘要翻译:其中A,R 1,R 2和R 3具有给定的含义的式I的4-巯基苯甲酰基胍,其生理上无反应的盐表现出抗心律失常性质,并且作为细胞Na + / H +反转录酶的抑制剂是有活性的。